resveratrol has been researched along with colchicine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Lu, X; Ruan, BF; Tang, JF; Wang, LS; Wang, XL; Wei, Y; Zhang, YB; Zhu, HL | 1 |
| Addlagatta, A; Jain, N; Kalivendi, SV; Kishore, C; P Surendra, R; Reddy, MA; Sreedhar, B; Vangala, JR; Yada, D | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Brouillard, R; Chabert, P; Coelho, D; Fougerousse, A; Gossé, F; Launay, JF; Raul, F; Schneider, Y; Stutzmann, J | 1 |
| Kumar, A; Naidu, PS; Padi, SS; Seghal, N | 1 |
| Muriel, P; Rivera-Espinoza, Y | 1 |
| Bae, I; Baruchello, R; Dakshanamurthy, S; Daniele, S; Grisolia, G; Hong, YB; Kang, HJ; Kim, HJ; Rondanin, R; Rosen, EM | 1 |
| Colin, D; Delmas, D; Fasseur, D; Gobbo, J; Latruffe, N; Mazué, F; Meunier, P; Rescifina, A; Spatafora, C; Tringali, C; Wegner, M | 1 |
| Fürst, R; Zündorf, I | 1 |
| Chen, Y; Jiang, M; Ren, D; Wang, P; Wang, R; Wang, YG | 1 |
| Crooks, PA; Penthala, NR; Thakkar, S | 1 |
| Bisen, PS; Bundela, S; Sharma, A | 1 |
| Kong, LY; Lian, BP; Shao, YY; Xia, YZ; Yin, Y | 1 |
2 review(s) available for resveratrol and colchicine
| Article | Year |
|---|---|
Beneficial drugs for liver diseases.
Topics: Adrenal Cortex Hormones; Animals; Colchicine; Curcumin; Disease Models, Animal; Drug Combinations; Glycyrrhizic Acid; Humans; Interferons; Liver Diseases; Nitric Oxide; Plant Extracts; Resveratrol; S-Adenosylmethionine; Silymarin; Stilbenes; Thalidomide | 2008 |
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress.
Topics: Animals; Anti-Inflammatory Agents; Capsaicin; Catechin; Colchicine; Curcumin; Humans; Imidazoles; Inflammation; Niacin; Resveratrol; Stilbenes | 2014 |
14 other study(ies) available for resveratrol and colchicine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
Topics: Binding Sites; Cell Line, Tumor; Chalcone; Dose-Response Relationship, Drug; Humans; Protein Binding; Resveratrol; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2011 |
Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents.
Topics: Antimitotic Agents; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Drug Design; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Microtubules; Models, Molecular; Nitro Compounds; Resveratrol; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tubulin Modulators; Vinyl Compounds | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Caco-2 Cells; Cell Cycle; Cell Division; Colchicine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gout Suppressants; Humans; Microtubules; Mitosis; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Polymers; Resveratrol; Stilbenes; Tubulin; Tubulin Modulators; Vinblastine | 2003 |
Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Antioxidants; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Glutathione; Injections, Intraventricular; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Space Perception; Stilbenes; Tubulin Modulators | 2007 |
Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.
Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Binding Sites; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; Cyclin B; Cyclin B1; G2 Phase; Humans; Microtubules; Models, Molecular; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Resveratrol; Stilbenes; Tubulin | 2009 |
Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.
Topics: Binding Sites; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; DNA; Humans; Hydroxides; Models, Molecular; Resveratrol; Stereoisomerism; Stilbenes; Tubulin | 2010 |
Effect of sodium alginate addition to resveratrol on acute gouty arthritis.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis, Gouty; Chemokine CXCL10; Colchicine; Disease Models, Animal; Drug Therapy, Combination; Glucuronic Acid; Hexuronic Acids; Interleukin-1beta; Mice; Receptors, CCR5; Resveratrol; Stilbenes; Uric Acid | 2015 |
Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Topics: Antineoplastic Agents; Benzofurans; Benzothiazoles; Binding Sites; Cell Line, Tumor; Cell Survival; Colchicine; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Resveratrol; Stilbenes; Thiophenes; Tubulin | 2015 |
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat | 2015 |
Design, synthesis and biological evaluation of resveratrol-cinnamoyl derivates as tubulin polymerization inhibitors targeting the colchicine binding site.
Topics: Binding Sites; Cell Proliferation; Cinnamates; Colchicine; Drug Design; HeLa Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Molecular Docking Simulation; Resveratrol; Tubulin Modulators | 2019 |